23814-12-2Relevant articles and documents
INDAZOLES AS LRRK2 INHIBITORS
-
Page/Page column 99, (2020/10/09)
The present invention is directed to indazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
The discovery of new scaffold of plant activators: From salicylic acid to benzotriazole
Chang, Kang,Chen, Jian-Qin,Shi, Yan-Xia,Sun, Mei-Jian,Li, Peng-Fei,Zhao, Zhen-Jiang,Zhu, Wei-Ping,Li, Hong-Lin,Xu, Yu-Fang,Li, Bao-Ju,Qian, Xu-Hong
, p. 919 - 926 (2017/05/16)
Started from salicylic acid (SA) and related commercialized plant activators, based on molecular three-dimensional shape and pharmacophore similarity comparison (SHAFTS), a new lead compound benzotriazole was predicted and a series of benzotriazole derivatives were designed and synthesized. The bioassay showed that benzotriazole had high activity against a broad spectrum of diseases including fungi and oomycetes in vivo, but no activity in vitro. And the introduction of proper groups at the 1’-position and 5’-position was beneficial to the activity. So, they had the potential to be exploited as novel plant activators.
Hydrolysis and oxidation of 1H-benzotriazole-carboxylic acid esters by rat liver microsomes
Jacobi,Hoffmann
, p. 825 - 827 (2007/10/02)
-